AQP4 and neuromyelitis optica: Studies demonstrated that a passive transfer by intravenous or intraperitoneal injection of the AQP4 antibodies from seropositive NMO patients was insufficient to cause NMO-like lesions in rodents, as the low levels of antibodies could not penetrate into the CNS [163,173].